New Delhi, Jun 10 () Shares of Panacea Biotec on Wednesday zoomed 20 per cent after the company said it was setting up a JV in Ireland with US-based Refana Inc to develop a vaccine for COVID-19.
Following the announcement, shares of Panacea Biotec advanced 20 per cent to Rs 202.80 -- its upper circuit limit -- on the BSE.
The scrip jumped 20 per cent to Rs 203.70 -- its highest trading permissible limit -- for the day on the NSE.
This article was written by Business Insider India.
Read the full article here.